ctrl K

Tenaya Therapeutics Inc. (TNYA)

0.49

-0.00 (-0.24%)

At close: Apr 28, 2025, 3:59 PM

0.48

-1.00%

After-hours: Apr 28, 2025, 05:43 PM EDT

Tenaya Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	8.69M	8.71M	4.03M	2.48M	1.99M
Gross Profit	n/a	-8.69M	-8.71M	-4.03M	-2.48M	-1.99M
Operating Income	-115.95M	-131.19M	-125.62M	-72.81M	-38.91M	-27.71M
Interest Income	4.74M	7.06M	1.95M	108K	87K	453K
Pretax Income	-111.13M	-124.08M	-123.67M	-72.72M	-38.4M	-26.23M
Net Income	-111.13M	-124.08M	-123.66M	-69.65M	-38.31M	-25.78M
Selling & General & Admin	29.21M	33.16M	31.08M	18.41M	7.81M	4.56M
Research & Development	86.74M	98.04M	94.54M	54.39M	31.1M	23.15M
Other Expenses	n/a	n/a	2K	-23K	430K	1.03M
Operating Expenses	115.95M	131.19M	125.62M	72.81M	38.91M	27.71M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	131.19M	125.62M	72.81M	38.91M	27.71M
Income Tax Expense	n/a	n/a	-1.96K	-3.07M	-87K	-453K
Shares Outstanding (Basic)	84.82M	73.79M	44.82M	41.29M	41.12M	41.12M
Shares Outstanding (Diluted)	84.82M	73.79M	44.82M	41.29M	41.12M	41.12M
EPS (Basic)	-1.31	-1.68	-2.76	-1.69	-0.93	-0.63
EPS (Diluted)	-1.31	-1.68	-2.76	-1.69	-0.93	-0.63
EBITDA	-115.95M	-122.51M	-114.95M	-68.7M	-36.43M	-25.72M
EBIT	n/a	-131.19M	-123.67M	-72.72M	-38.91M	-27.71M
Depreciation & Amortization	n/a	8.69M	8.71M	4.03M	2.48M	1.99M